Adverse Events Associated with Tirzepatide: Updated Pharmacovigilance Analysis Using FAERS (2022 Q1-2025 Q1) with an Adapted Time-to-Onset Method
Drug, Healthcare and Patient Safety · 2026-01 · Volume 18 · 1-13
DOI: 10.2147/dhps.s556918 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug, Healthcare and Patient Safety, 2026-01. Verfasst von Saisai Gu. Beteiligte Einrichtung: Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
ORCID-Profile: Saisai Gu
Zitieren
APA
Gu, S. (2026). Adverse Events Associated with Tirzepatide: Updated Pharmacovigilance Analysis Using FAERS (2022 Q1-2025 Q1) with an Adapted Time-to-Onset Method. Drug, Healthcare and Patient Safety, Volume 18, 1-13. https://doi.org/10.2147/dhps.s556918
Vancouver
Gu S. Adverse Events Associated with Tirzepatide: Updated Pharmacovigilance Analysis Using FAERS (2022 Q1-2025 Q1) with an Adapted Time-to-Onset Method. Drug, Healthcare and Patient Safety. 2026;Volume 18:1-13. doi:10.2147/dhps.s556918
BibTeX
@article{Gu2026,
author = {Gu, Saisai},
title = {Adverse Events Associated with Tirzepatide: Updated Pharmacovigilance Analysis Using FAERS (2022 Q1-2025 Q1) with an Adapted Time-to-Onset Method},
journal = {Drug, Healthcare and Patient Safety},
year = {2026},
volume = {Volume 18},
pages = {1--13},
doi = {10.2147/dhps.s556918}
}
EUVIMED